Xiaomeng Hao
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Mesenchymal stem cell research
Papers in
-
- Metabolism, Diabetes, and Cancer 3
- Epigenetics and DNA Methylation 1
- Oncology 6
- Cancer Risks and Factors 2
- Cancer-related Molecular Pathways 2
- Cancer Cells and Metastasis 2
- Co-authors
- Sheng Zhang (6 shared papers)Jin Zhang (3 shared papers)Yi Ma (1 shared paper)Xiaobei Zhang (3 shared papers)Guofang Hou (2 shared papers)Jingjing Liu (2 shared papers)Sheng Zhang (2 shared papers)Jin Zhang (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (2 papers)Scientific Reports (2 papers)The Prostate (1 paper)Frontiers in Oncology (1 paper)Theriogenology (1 paper)
- Partner nations
- ChinaUnited KingdomSweden
In The Last Decade
Xiaomeng Hao
16 papers receiving 379 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 133
- Genetics 51
- Oncology 106
- Molecular Biology 196
- Pulmonary and Respiratory Medicine 45
Countries citing papers authored by Xiaomeng Hao
This map shows the geographic impact of Xiaomeng Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomeng Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomeng Hao more than expected).
Fields of papers citing papers by Xiaomeng Hao
This network shows the impact of papers produced by Xiaomeng Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomeng Hao. The network helps show where Xiaomeng Hao may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaomeng Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 86 | |
| 2 | 2011 | 74 | |
| 3 | 2013 | 74 | |
| 4 | 2021 | 43 | |
| 5 | 2013 | 29 | |
| 6 | 2011 | 23 | |
| 7 | 2019 | 20 | |
| 8 | 2014 | 11 | |
| 9 | 2021 | 6 | |
| 10 | [Efficacy and safety analysis of paclitaxel liposome and docetaxel for the neoadjuvant chemotherapy of breast cancer]. | 2015 | 4 |
| 11 | 2025 | 3 | |
| 12 | [Prognostic significance of Ki-67 expression before and after neoadjuvant chemotherapy in different biological breast cancer phenotypes]. | 2014 | 3 |
| 13 | A gene encoding Era-binding protein exists in E. coli genome | 1997 | 2 |
| 14 | 2023 | 2 | |
| 15 | 2010 | 1 | |
| 16 | Clinicopathologic characteristics and prognostic analysis of luminal B breast cancer patients with diabetes | 2013 | 1 |
About Xiaomeng Hao
Xiaomeng Hao is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Genetics, having authored 16 papers that have together received 382 indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (3 papers), Estrogen and related hormone effects (2 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Risks and Factors (2 papers), Breast Cancer Treatment Studies (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer Cells and Metastasis (2 papers) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Cancer Research (133 citations), Genetics (51 citations), Oncology (106 citations), Molecular Biology (196 citations) and Pulmonary and Respiratory Medicine (45 citations). Xiaomeng Hao has collaborated with scholars based in China, United Kingdom and Sweden. Frequent co-authors include Sheng Zhang, Jin Zhang, Yi Ma, Xiaobei Zhang, Guofang Hou, Jingjing Liu, Sheng Zhang, Jin Zhang, Yan Liu and Sheng Zhang. Their work appears in journals such as Breast Cancer Research and Treatment, Scientific Reports, The Prostate, Frontiers in Oncology and Theriogenology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.